DK1663991T3 - Selektiv syntese af CF3-substituerede pyrimidiner - Google Patents
Selektiv syntese af CF3-substituerede pyrimidinerInfo
- Publication number
- DK1663991T3 DK1663991T3 DK04769170T DK04769170T DK1663991T3 DK 1663991 T3 DK1663991 T3 DK 1663991T3 DK 04769170 T DK04769170 T DK 04769170T DK 04769170 T DK04769170 T DK 04769170T DK 1663991 T3 DK1663991 T3 DK 1663991T3
- Authority
- DK
- Denmark
- Prior art keywords
- substituted pyrimidines
- selective synthesis
- selective
- synthesis
- pyrimidines
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50073303P | 2003-09-05 | 2003-09-05 | |
| PCT/IB2004/002744 WO2005023780A1 (en) | 2003-09-05 | 2004-08-24 | Selective synthesis of cf3-substituted pyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1663991T3 true DK1663991T3 (da) | 2007-04-10 |
Family
ID=34272990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04769170T DK1663991T3 (da) | 2003-09-05 | 2004-08-24 | Selektiv syntese af CF3-substituerede pyrimidiner |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7122670B2 (pl) |
| EP (1) | EP1663991B1 (pl) |
| JP (1) | JP4842816B2 (pl) |
| KR (1) | KR100694732B1 (pl) |
| CN (1) | CN100465164C (pl) |
| AR (1) | AR045557A1 (pl) |
| BR (1) | BRPI0414059B8 (pl) |
| CA (1) | CA2537373C (pl) |
| CO (1) | CO5650237A2 (pl) |
| CY (1) | CY1106370T1 (pl) |
| DE (1) | DE602004004287T2 (pl) |
| DK (1) | DK1663991T3 (pl) |
| ES (1) | ES2276344T3 (pl) |
| IL (1) | IL173363A (pl) |
| MX (1) | MXPA06002552A (pl) |
| NO (1) | NO334383B1 (pl) |
| NZ (1) | NZ544969A (pl) |
| PL (1) | PL1663991T3 (pl) |
| PT (1) | PT1663991E (pl) |
| RU (1) | RU2315759C2 (pl) |
| TW (1) | TWI283667B (pl) |
| WO (1) | WO2005023780A1 (pl) |
| ZA (1) | ZA200600747B (pl) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH072586Y2 (ja) | 1988-11-25 | 1995-01-25 | 日東紡績株式会社 | ガラス繊維紡糸用冷却フィン装置 |
| MXPA06002608A (es) * | 2002-12-20 | 2007-01-23 | Pfizer Prod Inc | Derivados de pirimidina para el tratamiento del crecimiento celular anormal. |
| US20060205945A1 (en) * | 2004-05-14 | 2006-09-14 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| JP4778717B2 (ja) * | 2005-03-25 | 2011-09-21 | 富士フイルム株式会社 | 複素環式化合物の製造方法 |
| DE102007010801A1 (de) | 2007-03-02 | 2008-09-04 | Bayer Cropscience Ag | Diaminopyrimidine als Fungizide |
| JP4782239B2 (ja) | 2007-04-18 | 2011-09-28 | ファイザー・プロダクツ・インク | 異常細胞増殖治療のためのスルホニルアミド誘導体 |
| KR101294731B1 (ko) * | 2007-06-04 | 2013-08-16 | 삼성디스플레이 주식회사 | 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법 |
| UY31714A (es) | 2008-03-20 | 2009-11-10 | Boehringer Ingelheim Int | Preparación selectiva de pirimidinas sustituidas |
| CA2718858A1 (en) | 2008-03-20 | 2009-09-24 | Boehringer Ingelheim International Gmbh | Selective synthesis of substituted pyrimidines |
| DE102009006643A1 (de) | 2009-01-29 | 2010-08-05 | Saltigo Gmbh | Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten |
| TW201100441A (en) | 2009-06-01 | 2011-01-01 | Osi Pharm Inc | Amino pyrimidine anticancer compounds |
| WO2011018517A1 (en) | 2009-08-14 | 2011-02-17 | Boehringer Ingelheim International Gmbh | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
| US8933227B2 (en) * | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
| PT2646448T (pt) | 2010-11-29 | 2017-10-04 | Osi Pharmaceuticals Llc | Inibidores macrocíclicos de cinases |
| UY33817A (es) | 2010-12-21 | 2012-07-31 | Boehringer Ingelheim Int | ?nuevas oxindolpirimidinas bencílicas?. |
| JP5937112B2 (ja) | 2011-02-17 | 2016-06-22 | カンサー・セラピューティクス・シーアールシー・プロプライエタリー・リミテッドＣａｎｃｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｒｃ Ｐｔｙ Ｌｉｍｉｔｅｄ | 選択的ｆａｋ阻害剤 |
| ES2691673T3 (es) | 2011-02-17 | 2018-11-28 | Cancer Therapeutics Crc Pty Limited | Inhibidores de Fak |
| WO2014126954A1 (en) | 2013-02-13 | 2014-08-21 | OSI Pharmaceuticals, LLC | Regioselective synthesis of substituted pyrimidines |
| US9656970B2 (en) | 2014-05-08 | 2017-05-23 | Tosoh F-Tech, Inc. | 5-(trifluoromethyl)pyrimidine derivatives and method for producing same |
| JP6391985B2 (ja) * | 2014-05-16 | 2018-09-19 | 東ソー・ファインケム株式会社 | ２−置換−４−（２，２，２−トリフルオロエトキシ）−５−（トリフルオロメチル）ピリミジン誘導体及びその製造方法 |
| JP6391988B2 (ja) * | 2014-05-21 | 2018-09-19 | 東ソー・ファインケム株式会社 | ５−（トリフルオロメチル）ピリミジン誘導体の製造方法及び新規５−（トリフルオロメチル）ピリミジン誘導体 |
| CN108440499A (zh) * | 2018-03-22 | 2018-08-24 | 盐城师范学院 | 一种色瑞替尼及其关键中间体的制备方法 |
| CN114213339B (zh) * | 2021-12-20 | 2023-10-31 | 苏州康纯医药科技有限公司 | 一种表皮细胞生长因子受体突变抑制剂的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2896532B2 (ja) * | 1994-08-13 | 1999-05-31 | ユーハン コーポレーション | 新規なピリミジン誘導体およびその製造方法 |
| WO2003030909A1 (en) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| ES2314106T3 (es) * | 2001-10-17 | 2009-03-16 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | Derivados de pirimidina, agentes farmaceuticos que contiene dichos compuestos, uso y metodo para su obtencion. |
-
2004
- 2004-08-24 RU RU2006106727/04A patent/RU2315759C2/ru not_active IP Right Cessation
- 2004-08-24 ES ES04769170T patent/ES2276344T3/es not_active Expired - Lifetime
- 2004-08-24 PT PT04769170T patent/PT1663991E/pt unknown
- 2004-08-24 MX MXPA06002552A patent/MXPA06002552A/es active IP Right Grant
- 2004-08-24 DK DK04769170T patent/DK1663991T3/da active
- 2004-08-24 CA CA002537373A patent/CA2537373C/en not_active Expired - Lifetime
- 2004-08-24 KR KR1020067004428A patent/KR100694732B1/ko not_active Expired - Lifetime
- 2004-08-24 EP EP04769170A patent/EP1663991B1/en not_active Expired - Lifetime
- 2004-08-24 NZ NZ544969A patent/NZ544969A/en not_active IP Right Cessation
- 2004-08-24 JP JP2006525198A patent/JP4842816B2/ja not_active Expired - Lifetime
- 2004-08-24 WO PCT/IB2004/002744 patent/WO2005023780A1/en not_active Ceased
- 2004-08-24 PL PL04769170T patent/PL1663991T3/pl unknown
- 2004-08-24 BR BRPI0414059A patent/BRPI0414059B8/pt not_active IP Right Cessation
- 2004-08-24 DE DE602004004287T patent/DE602004004287T2/de not_active Expired - Lifetime
- 2004-08-24 CN CNB2004800254318A patent/CN100465164C/zh not_active Expired - Lifetime
- 2004-08-27 US US10/928,954 patent/US7122670B2/en not_active Expired - Lifetime
- 2004-09-02 AR ARP040103140A patent/AR045557A1/es not_active Application Discontinuation
- 2004-09-03 TW TW093126748A patent/TWI283667B/zh not_active IP Right Cessation
-
2006
- 2006-01-25 IL IL173363A patent/IL173363A/en active IP Right Grant
- 2006-01-26 ZA ZA200600747A patent/ZA200600747B/xx unknown
- 2006-02-23 CO CO06018320A patent/CO5650237A2/es not_active Application Discontinuation
- 2006-04-03 NO NO20061509A patent/NO334383B1/no unknown
-
2007
- 2007-03-12 CY CY20071100341T patent/CY1106370T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1663991T3 (da) | Selektiv syntese af CF3-substituerede pyrimidiner | |
| DK1778618T3 (da) | Syntese af triethylentetraminer | |
| DK1658295T3 (da) | Regioselektiv syntese af CCI-779 | |
| DK1476162T3 (da) | Kontrolleret syntese af ziprasidone | |
| EP1546115A4 (en) | Substituted pyrimidines | |
| DK2377869T3 (da) | Syntese af Bortezomib | |
| DK1487805T3 (da) | Pyrimidinderivater | |
| DK3470535T3 (da) | Forudsigelse af sandsynlighed for tilbagevenden af cancer | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| IS7007A (is) | Kristallaform af asiþrómýsíni | |
| SI1897548T2 (sl) | Regulacija celic T | |
| DK1360169T3 (da) | Succinatsalt af O-desmethyl-venlafaxin | |
| DK1587542T3 (da) | Anvendelse af anti-CD100-antistoffer | |
| FI7526U1 (fi) | Kiteinen bikalutamidi | |
| DK1840125T3 (da) | Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater | |
| DK1470732T3 (da) | Fremskaffelse af lokaliseringsinformation | |
| NO20033679D0 (no) | Nye pyrimidinforbindelser | |
| DK1516540T3 (da) | Anvendelse af vitamin D-forbindelser | |
| ATE356124T1 (de) | Hydroxyalkylsubstituierte pyrido-7-pyrimidin-7- one | |
| DK1625153T3 (da) | Acylerede nonadepsipeptider af typen Lysobactin | |
| DK1578731T3 (da) | Fremgangsmåde til fremstilling af pyrimidinforbindelser | |
| DK1578774T3 (da) | Oprensning af immunoglobuliner | |
| ITMN20030043A1 (it) | Doccetta per lavello | |
| DK1651618T3 (da) | 2-substituerede pyrimidiner | |
| DK1631261T3 (da) | Fremstilling af små partikler |